| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/24/2002 | EP1224945A1 Tension-relieving agents for ciliary muscle |
| 07/24/2002 | EP1224941A2 Antithrombin III used in diseases caused by angiogenesis |
| 07/24/2002 | EP1224940A1 Liquid interferon-beta formulations |
| 07/24/2002 | EP1224939A1 Interferon complex and medicinal use thereof |
| 07/24/2002 | EP1224929A2 Powder formulations containing melezitose as a diluent |
| 07/24/2002 | EP1224471A2 Dpi-6, a therapeutic biomarker in neurological disorders |
| 07/24/2002 | EP1224469A1 Method of screening for inhibitors of asp2 |
| 07/24/2002 | EP1224333A2 Methods and compositions for correlating ccr5 expression with essential hypertension |
| 07/24/2002 | EP1224313A1 Adeno-associated viruses and uses thereof |
| 07/24/2002 | EP1224305A2 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 07/24/2002 | EP1224303A2 Tms1 compositions and methods of use |
| 07/24/2002 | EP1224302A2 Modified viral surface proteins which bind to cells of tumor vasculature |
| 07/24/2002 | EP1224299A2 Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics |
| 07/24/2002 | EP1224298A1 Fibrinolytically active polypeptide |
| 07/24/2002 | EP1224291A1 Multiple sclerosis-related superantigen |
| 07/24/2002 | EP1224290A1 Disulfide conjugated cell toxins and methods of making and using them |
| 07/24/2002 | EP1224288A2 Processed human chemokines phc-1 and phc-2 |
| 07/24/2002 | EP1224285A2 27 human secreted proteins |
| 07/24/2002 | EP1224284A1 Gene upregulated in cancers of the prostate |
| 07/24/2002 | EP1224283A2 Human and rat fgf-20 genes and gene expression products |
| 07/24/2002 | EP1224282A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224280A2 Design of high affinity rnase h recruiting oligonucleotide |
| 07/24/2002 | EP1224274A1 Tumor necrosis factor related receptor, tr6 |
| 07/24/2002 | EP1224271A1 Expression of recombinant mature lysostaphin |
| 07/24/2002 | EP1224268A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 07/24/2002 | EP1224266A2 Lysosomal targeting pathway enzymes |
| 07/24/2002 | EP1224261A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 07/24/2002 | EP1224223A1 Immunointeractive molecules and their uses in treating subjects suffering from hev b 5 allergies |
| 07/24/2002 | EP1224221A1 Transcription factor-selective nuclear transport receptors required for immune response activation |
| 07/24/2002 | EP1224220A2 Epo primary response gene 1, eprg1 |
| 07/24/2002 | EP1224219A1 Beta-defensins |
| 07/24/2002 | EP1224218A1 Dna encoding human alpha1g-c t-type calcium channel |
| 07/24/2002 | EP1224217A2 Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines |
| 07/24/2002 | EP1224216A1 Mage-a1 peptides presented by hla class ii molecules |
| 07/24/2002 | EP1224215A1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE |
| 07/24/2002 | EP1224213A2 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 07/24/2002 | EP1224212A1 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof |
| 07/24/2002 | EP1224210A2 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224203A2 Antisense modulation of protein kinase c-theta expression |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224200A1 Tissue plasminogen activator-like protease |
| 07/24/2002 | EP1224197A1 Hygromycin derivatives |
| 07/24/2002 | EP1224022A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/24/2002 | EP1223990A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 07/24/2002 | EP1223988A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 07/24/2002 | EP1223986A2 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 07/24/2002 | EP1223985A2 Dialysis solution including polyglycol osmotic agent |
| 07/24/2002 | EP1223983A2 Methods and compositions for predicting, diagnosing and treating lipodystrophy |
| 07/24/2002 | EP1223981A1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 07/24/2002 | EP1223978A2 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 07/24/2002 | EP1223977A2 Modified plant viruses and methods of use thereof |
| 07/24/2002 | EP1223974A2 Medicament in order to induce tolerance |
| 07/24/2002 | EP1223972A1 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 07/24/2002 | EP1223971A2 Compositions and methods for preventing and treating transplant rejection |
| 07/24/2002 | EP1223970A1 Short segments of dap-kinase |
| 07/24/2002 | EP1223969A2 Combined use of a plasminogen activator and il-2 inhibitors for neuroprotection |
| 07/24/2002 | EP1223968A2 Use of urodilatin for treating chronic kidney failure with residual kidney functions |
| 07/24/2002 | EP1223967A1 Fc GAMMA RIA |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223965A2 Modulation of angiogenesis |
| 07/24/2002 | EP1223964A1 April receptor (bcma) and uses thereof |
| 07/24/2002 | EP1223963A2 T-cells and molecules involved in immune regulation |
| 07/24/2002 | EP1223962A1 Method and compositions for inhibiting adhesion formation |
| 07/24/2002 | EP1223961A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 07/24/2002 | EP1223960A2 Pharmaceutical agent preparations |
| 07/24/2002 | EP1223959A2 Inhbition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain |
| 07/24/2002 | EP1223958A2 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 07/24/2002 | EP1223957A1 A method of treating erectile dysfunction |
| 07/24/2002 | EP1223955A1 Fibrin sealants providing less inflammatory response and methods using same |
| 07/24/2002 | EP1223953A1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 07/24/2002 | EP1223950A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 07/24/2002 | EP1223946A1 Human neuropeptide receptor |
| 07/24/2002 | EP1223945A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 07/24/2002 | EP1223943A2 Therapeutic use of an inhibitor or an antagonist of an abc protein in bone |
| 07/24/2002 | EP1223941A2 Therapeutic treatments comprising administratoin of certain steroids for blood cell deficiencies |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1185260A4 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 07/24/2002 | EP1146896B1 Monodisperse hexameric acylated insulin analog formulations |
| 07/24/2002 | EP1119367A4 Method of using fetuin to induce apoptosis in cancer cells |
| 07/24/2002 | EP1059934B1 Matrix protein compositions for wound healing |
| 07/24/2002 | EP1056357B1 Calorically dense nutritional composition |
| 07/24/2002 | EP0886647B1 Serine protease inhibitors |
| 07/24/2002 | EP0835263B9 Somatostatin peptides |
| 07/24/2002 | EP0800579B1 Combination gene delivery vehicles |
| 07/24/2002 | EP0799030B1 Powder formulations containing melezitose as a diluent |
| 07/24/2002 | EP0753577B1 Cell-surface polypeptide gene |
| 07/24/2002 | EP0719340B1 Cloned glutamic acid decarboxylase |
| 07/24/2002 | EP0693941B1 Radiolabeled compounds for thrombus imaging |
| 07/24/2002 | EP0684835B1 Ligand antagonists for treatment of breast cancer |
| 07/24/2002 | EP0664832B1 Remyelination using neural stem cells |
| 07/24/2002 | EP0621285B1 Novel megakaryocyte potentiator |
| 07/24/2002 | EP0579640B1 Glial mitogenic factors, their preparation and use |
| 07/24/2002 | CN1360636A Modified human granulocyte-colony stimulating factor and process for producing same |
| 07/24/2002 | CN1360633A Fucosyl transferase gene |
| 07/24/2002 | CN1360629A Induction of vascular endothelial growth factor (VEGF) by serine/threonine protein kinase AKT |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360595A Immunogenic peptides derived from MAGE and use thereof |
| 07/24/2002 | CN1360593A Pseudomycin N-acyl side-chain analogs |